Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis

Lampertico P, Carrión JA, Curry M, et al. Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis. J Hepatol. 2020;72(6):1112-1121.

Publication Type:

Journal Article

Authors:

Lampertico, P; Carrión, JA; Curry, M; et, al

Source:

J Hepatol., Volume 72, Issue 6, p.1112-1121 (2020)

Cited On:

Export Citation:

RIS Format

Top